Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011630 |
---|---|
Receipt number | R000011778 |
Scientific Title | THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0.6 mg/kg (THAWS) Trial |
Date of disclosure of the study information | 2013/09/09 |
Last modified on | 2020/12/15 10:43:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/09/02 19:14:24 | ||
2 | Update | 2013/09/06 10:50:35 | Randomization unit Blinding |
|
3 | Update | 2013/09/06 10:51:58 | Key secondary outcomes |
|
4 | Update | 2013/09/06 10:54:53 | Nationality of Funding Organization Nationality of Funding Organization Institutions |
|
5 | Update | 2013/09/06 11:17:07 | Institutions |
|
6 | Update | 2015/01/16 11:21:00 | Homepage URL |
|
7 | Update | 2015/01/19 13:11:27 | Recruitment status Last follow-up date URL releasing protocol |
|
8 | Update | 2015/01/19 13:18:55 | Institutions |
|
9 | Update | 2015/01/19 13:20:02 | Public title |
|
10 | Update | 2015/01/19 13:20:38 | Anticipated trial start date |
|
11 | Update | 2015/01/19 16:18:24 | Institutions |
|
12 | Update | 2015/01/27 17:53:08 | Institutions |
|
13 | Update | 2015/09/01 10:43:47 | Key inclusion criteria Key inclusion criteria |
|
14 | Update | 2015/09/01 10:49:46 | Organization Organization Category of Funding Organization Name of secondary funder(s) Name of secondary funder(s) |
|
15 | Update | 2015/09/01 12:47:11 | Name of secondary funder(s) Name of secondary funder(s) Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Institutions |
|
16 | Update | 2015/10/02 16:59:22 | Email1 |
|
17 | Update | 2017/11/01 08:55:28 | Last follow-up date URL related to results and publications Results |
|
18 | Update | 2018/03/07 11:36:02 | Name of primary person or sponsor Organization Category of Funding Organization |
|
19 | Update | 2018/03/07 11:40:51 | Results Results |
|
20 | Update | 2018/03/07 11:51:13 | Institutions |
|
21 | Update | 2018/03/07 12:00:56 | UMIN ID1 |
|
22 | Update | 2018/04/24 16:56:23 | Key secondary outcomes |
|
23 | Update | 2018/04/24 16:56:54 | Results Results |
|
24 | Update | 2018/04/24 17:08:57 | Key secondary outcomes |
|
25 | Update | 2018/05/08 14:34:48 | Key secondary outcomes |
|
26 | Update | 2018/09/11 12:42:03 | Key secondary outcomes Key secondary outcomes |
|
27 | Update | 2018/09/11 12:43:21 | Recruitment status Results Results |
|
28 | Update | 2019/03/05 09:18:06 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
29 | Update | 2019/03/05 12:11:01 | Date trial data considered complete Date analysis concluded |
|
30 | Update | 2019/03/05 22:50:52 | Last follow-up date Date of closure to data entry |
|
31 | Update | 2019/03/11 20:23:14 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Division name Division name Zip code Organization Organization Address Address Tel |
|
32 | Update | 2019/03/11 20:24:58 | Date of IRB |
|
33 | Update | 2019/03/11 20:25:55 | Number of participants that the trial has enrolled Results date posted |
|
34 | Update | 2019/03/13 09:33:01 | Recruitment status |
|
35 | Update | 2020/08/18 10:57:07 | Publication of results Results Results Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
36 | Update | 2020/12/15 10:43:19 | Other related information Other related information |